NVO•benzinga•
Novo Nordisk Q3 2024 GAAP EPS DKK6.12 Beats DKK6.02 Estimate, Sales DKK71.311B Miss DKK71.891B Estimate
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on November 6, 2024 by benzinga